Akron Bio, a developer and manufacturer of critical building blocks used by biopharma to produce advanced therapies for the prevention and treatment of cardiovascular diseases and cancers, has launched a new, state-of-the-art cGMP plasmid DNA manufacturing facility in Sarasota, FL. Akron Bio’s Sarasota facility will address critical demands in the rapidly growing gene therapy and vaccine markets by providing plasmid DNA, an important ancillary material used in the manufacture of advanced ther...